Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | EGFRt/19-28z/4-1BBL CAR T cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
EGFRt/19-28z/4-1BBL CAR T cells are autologous T-cells engineered to express TNFSF9 (4-1BBL) and a chimeric antigen receptor (CAR) targeting CD19 linked to CD28 and CD3zeta signaling domains as well as a truncated EGFR, which may relieve immunosuppression and enhance cytotoxicity against CD19-expressing tumor cells (NCI Thesaurus). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | C133189 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
EGFRt/19-28z/4-1BBL CAR T cells | EGFRt/19-28z/4-1BBL CAR T cells | 0 | 1 |